Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY:BSX)

45.60 +2.54 (+5.91%)
Streaming Delayed Price Updated: 12:35 PM EDT, Jul 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
29 30 Next >
News headline image
German Pharma Firm Bayer's New Parkinson's Treatment Shows Promise: What the Phase 1 Trial Reveals ↗
Boston Scientific Corporation (NYSE: BSX) released 12-month results from the pivotal ADVENT trial of the FARAPULSE Pulsed Field Ablation (PFA) System, a nonthermal treatment in which electric fields... 
Via Benzinga
News headline image
Why Is Boston Scientific Stock Trading Higher Today? ↗
Boston Scientific Corporation (NYSE: BSX) released 12-month results from the pivotal ADVENT trial of the FARAPULSE Pulsed Field Ablation (PFA) System, a nonthermal treatment in which electric fields... 
Via Benzinga
News headline image
Analyst Expectations for Boston Scientific's Future ↗
 
Via Benzinga
News headline image
Boston Scientific Stock Gets 81 RS Rating After Profit Pops 56% In Year ↗
Boston Scientific stock rose from a 34.98 low on June 16, 2022, amid the bear market, to an all-time high 54.66 close on June 22 this year. 
Via Investor's Business Daily
News headline image
Target, Pinterest And 2 Other Stocks Insiders Are Selling ↗
The Nasdaq 100 closed slightly lower on Tuesday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
News headline image
$100 Invested In This Stock 15 Years Ago Would Be Worth $400 Today ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About Boston Scientific? ↗
 
Via Benzinga
News headline image
Here's How Much $100 Invested In Boston Scientific 10 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
Expert Ratings for Boston Scientific ↗
 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Boston Scientific's Farapulse Eyes Stronger US Market Position With Potential FDA Approval ↗
Boston Scientific Corp (NYSE: BSX) will present results from ADVENT pivotal trial for its Farapulse Pulsed Field Ablation (PFA) system at the 2023 European Society of Cardiology Congress on 27 August.... 
Via Benzinga
News headline image
Barron's Weekend Stock Picks: PayPal, Nikola And Icahn Enterprises' Challenges ↗
Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read. 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About Boston Scientific? ↗
 
Via Benzinga
News headline image
$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,500 Today ↗
 
Via Benzinga
News headline image
What 16 Analyst Ratings Have To Say About Boston Scientific ↗
 
Via Benzinga
News headline image
Peering Into Boston Scientific's Recent Short Interest ↗
 
Via Benzinga
News headline image
Boston Scientific Q2 Earnings Surpass Estimates - Here's How It Foresees FY23 ↗
Boston Scientific Corp (NYSE: BSX) generated Q2 revenues of $3.59 billion, beating the Wall Street estimate of $3.50 billion 
Via Benzinga
News headline image
BSX Stock Near Buy Point: Boston Scientific Earnings Beat; Medical Giant Raises Guidance ↗
BSX stock rose slightly, near a buy point. 
Via Investor's Business Daily
News headline image
Big Weeks Ahead For MedTech And Life Science Stocks ↗
It’s a big week for earnings that may change the trajectory of the rally but more than likely will continue the rotation into different sectors. 
Via Talk Markets
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2023 ↗
 
Via Benzinga
News headline image
Here's How Much $1000 Invested In Boston Scientific 10 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
Expert Ratings for Boston Scientific ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023 ↗
 
Via Benzinga
News headline image
DexCom Clears Base, Wall Street Eyes Double-Digit Earnings Growth
DexCom's G7 glucose-monitoring solution is driving revenue growth at the company. Analysts expect strong double-digit EPS growth this year and next. 
Via MarketBeat
News headline image
Here's How Much $1000 Invested In Boston Scientific 10 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
Healthcare Stocks Delivering Healthy Returns: 5 Stock Picks Investors Are Keeping On Their Radar ↗
Demand for healthcare and healthcare insurance is projected to see continuous growth over the coming months. 
Via Talk Markets
News headline image
Surgical Centers, Med-Tech Stocks Up On Pent-Up Surgical Demand
Surgery centers and medtech firms see a surge in demand as joint replacements and other elective surgeries are rescheduled, causing challenges for insurers. 
Via MarketBeat
News headline image
UnitedHealth's Bad News Hits Insurers, But Surgery Partners Signals Breakout ↗
UNH stock slumped after UnitedHealth said more seniors are getting hip and surgery procedures. That sent Surgery Partners stock soaring. 
Via Investor's Business Daily
News headline image
3 Sizzling Growth Stocks to Buy for 2023’s Second Half ↗
While some experts expect a recession later this year, here are three high-potential stocks for the second half of 2023. 
Via InvestorPlace
< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
29 30 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.